FDA Approves Nasal Spray Influenza Vaccine for Self- or …
Sep 20, 2024 · For Immediate Release: September 20, 2024. Spanish. Today, the U.S. Food and Drug Administration approved FluMist for self- or caregiver-administration. FluMist is approved for the prevention of...
FDA approves first flu vaccine that can be self-administered at …
Sep 20, 2024 · The US Food and Drug Administration on Friday approved the first flu vaccine that does not have to be administered by a health care provider, but it won’t be available in time for this ...
No needles required: The FDA approves an at-home flu vaccine
Sep 20, 2024 · The Food and Drug Administration has approved the first flu vaccine that people can administer to themselves at home. The agency on Friday gave the green light for people who have been screened...
US Will Transition to Trivalent Flu Vaccines for 2024–2025
On March 5, 2024, FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) met and recommended that all U.S. flu vaccines be three-component (trivalent) vaccines for the 2024–2025 flu season.
US FDA approves AstraZeneca's self-administered nasal spray flu vaccine
Sep 20, 2024 · The U.S. Food and Drug Administration said on Friday it has approved AstraZeneca's nasal spray flu vaccine for self-administration, making it the first of its kind.
FDA approves first self-administered flu vaccine spray - CBS News
Sep 20, 2024 · The Food and Drug Administration announced Friday it had broadened the approval of the FluMist nasal spray to become the first "self-administered" influenza vaccine — though a delay in the ...
FDA’s Critical Role in Ensuring Safe and Effective Flu Vaccines
Oct 23, 2024 · The FDA and HHS are working on developing new and better technologies for producing flu vaccines. The flu vaccine you get is the year-round work of highly skilled microbiologists, epidemiologists ...
Nasal Flu Vaccine FluMist Gets FDA Approval for At-Home Use
Oct 4, 2024 · Recently, the Food and Drug Administration (FDA) removed those obstacles by approving the at-home use of FluMist®, an influenza vaccine administered by nasal spray. Made by AstraZeneca, FluMist will be available for home use starting in the fall of 2025. It is approved for people ages 2 through 49 (the vaccine doesn’t help prevent flu in ...
US FDA accepts AstraZeneca's self-administered flu vaccine for …
Oct 24 (Reuters) - AstraZeneca (AZN.L) said on Tuesday the U.S. Food and Drug Administration (FDA) has accepted for review the company's application seeking approval for patients or caregivers...
FDA's Critical Role in Ensuring Supply of Influenza Vaccine
Oct 17, 2022 · In addition, the FDA has approved a high-dose and an adjuvanted vaccine specifically for people ages 65 and older, who typically bear the greatest burden of severe influenza disease and...